(Q38056632)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111637%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Roles of Wnt signals in bone resorption during physiological and pathological states (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111637%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111637%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Kazuhiro Maeda

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111637%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Naoyuki Takahashi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111637%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

31 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111637%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Medicine

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111637%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111637%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111637%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

15-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23111637%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00109-012-0974-0

16 February 2020

exact match

0 references

cites work

Osteoblastic cells are involved in osteoclast formation.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Genetic regulation of osteoclast development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Matrix-embedded cells control osteoclast formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

RANK is essential for osteoclast and lymph node development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Osteoprotection by semaphorin 3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

The Wnt signaling pathway in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Wnt5a functions in planar cell polarity regulation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Lrp5 functions in bone to regulate bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

New targets for intervention in the treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Wnt signaling regulates hemopoiesis through stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Biphasic and dosage-dependent regulation of osteoclastogenesis by β-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Identification of cell cycle-arrested quiescent osteoclast precursors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Lineage-committed osteoclast precursors circulate in blood and settle down into bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Osteoimmunology and the effects of the immune system on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Expression and function of wingless and frizzled homologs in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Genetic control of skeletal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0974-0

Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass

21 January 2018

1 reference

12 December 2020

Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis

1 reference

12 December 2020

Dickkopf-1 is a master regulator of joint remodeling

1 reference

12 December 2020

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

1 reference

12 December 2020